Bioenvision Reports 2006 Year-End Financial Results

September 11, 2006 |

1 min read

NEW YORK--(BUSINESS WIRE)--Sept. 11, 2006--Bioenvision (NasdaqGM:BIVN) today announced financial results for its fourth quarter and fiscal year ended June 30, 2006. Highlights of the year include:

Earnings

MORE ON THIS TOPIC

Business meeting idea and planning with strategy as a corporate concept with a mechanical wheel bridge as diverse multiracial businesspeople joining together as a symbol for people diversity and success with 3D render elements.

Earnings

Biogen’s ‘Bridge To Growth’ Cuts Through a Stacked Phase 3 Pipeline

February 6, 2026

·

2 min read

·

Annalee Armstrong

IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch

IPO

Eikon Clocks Largest IPO Since 2024, Generate, AgomAb Follow

February 6, 2026

·

5 min read

·

Tristan Manalac

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Charles River, Thermo Fisher Lay Off Staff Amid Site Closures

February 6, 2026

·

51 min read

·

BioSpace Editorial Staff

FDA Commissioner Dr. Marty Makary delivers remarks after President Donald Trump made an announcement on drug pricing, Tuesday, September 30, 2025, in the Oval Office. (Official White House Photo by Joyce N. Boghosian)

GLP-1

Makary Blasts ‘Illegal Copycat Drugs’ as Hims Launches Compounded Wegovy Pill

February 6, 2026

·

1 min read

·

Tristan Manalac